HLK Biotech Holding Group, Inc. (AMHD)

HLK Biotech Holding Group Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 1999	FY 1998
Period Ending	Jun 30, 1999	Jun 30, 1998
Net Income	-1.04	-0.96
Depreciation & Amortization	0.01	-
Asset Writedown & Restructuring Costs	0.32	-
Stock-Based Compensation	0.01	0.06
Other Operating Activities	-0.01	-
Change in Accounts Payable	0.26	0.25
Change in Other Net Operating Assets	0	-0.72
Operating Cash Flow	-0.44	-1.37
Cash Acquisitions	0.01	-
Investment in Securities	-0.11	-
Other Investing Activities	-0.21	-
Investing Cash Flow	-0.31	-
Short-Term Debt Issued	0.68	-
Total Debt Issued	0.68	0.24
Long-Term Debt Repaid	-0.02	-
Net Debt Issued (Repaid)	0.66	0.24
Issuance of Common Stock	0.2	1.2
Other Financing Activities	-0.04	-0.06
Financing Cash Flow	0.82	1.38
Net Cash Flow	0.06	0.01
Levered Free Cash Flow	-0.22	-
Unlevered Free Cash Flow	-0.22	-
Change in Working Capital	0.27	-0.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.